logo conference-reports

Conference Reports

Educational funding by logo MSD Oncology

ESMO ASIA 2019 – Advanced breast cancer: safety and efficacy of everolimus plus exemestane in a broader ethnic population

Final findings of the phase 3b EVEREXES trial.